Prevention of breast cancer in the context of a national breast screening programme (Q57266562)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Prevention of breast cancer in the context of a national breast screening programme (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Jane Warwick

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Jamie C Sergeant

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

William G. Newman

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Iain Buchan

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Gareth Evans

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

S Astley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

P Stavrinos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

S Sahin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

S Ingham

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

H McBurney

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

B Eckersley

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M Harvie

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M Wilson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

U Beetles

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

R Warren

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

A Hufton

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

J Cuzick

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

English

0 references

publication date

1 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

Journal of Internal Medicine

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

271

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

321-330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2002

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Women's reproductive cancers in evolutionary context

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Dual effects of weight and weight gain on breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Interpreting the epidemiological evidence linking obesity and cancer: A framework for population-attributable risk estimations in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

21 January 2018

Familial breast cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

21 January 2018

Cancer genetics clinics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Incorporating tumour pathology information into breast cancer risk prediction algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

A breast cancer prediction model incorporating familial and personal risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Screening younger women with a family history of breast cancer – does early detection improve outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Validation studies for models projecting the risk of invasive and total breast cancer incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Validation of the Gail et al. model for predicting individual breast cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Breast cancer risk assessment in the Czech female population--an adjustment of the original Gail model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Gail Model for Prediction of Absolute Risk of Invasive Breast Cancer: Independent Evaluation in the Florence–European Prospective Investigation Into Cancer and Nutrition Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Predicting risk of breast cancer in postmenopausal women by hormone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Assessing women at high risk of breast cancer: a review of risk assessment models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Genome-wide association study identifies five new breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Genome-based prediction of breast cancer risk in the general population: a modeling study based on meta-analyses of genetic associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Estimation of effect size distribution from genome-wide association studies and implications for future discoveries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Predicting the future of genetic risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Preventive therapy for breast cancer: a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Overview of the main outcomes in breast-cancer prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Exemestane for breast-cancer prevention in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Adult weight change and risk of postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Does intentional weight loss reduce cancer risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Weight loss and postmenopausal breast cancer in a prospective cohort of overweight and obese US women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Single reading with computer-aided detection and double reading of screening mammograms in the United Kingdom National Breast Screening Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Volume of mammographic density and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02525.X

10.1111/J.1365-2796.2012.02525.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292490%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference